logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
29/07/2025
Goldman Sachs raised its rating on Innovent Biologics from neutral to buy, with a target price of 29 yuan. Goldman Sachs also raised its rating on Aier Eye Hospital from neutral to buy, with a target price of 15 yuan.
Latest
now
Warner Bros. Discovery, Inc. Announces Company Name and Leadership Appointments Following Spin Off.
6 m ago
The yield on 2/10-year German bonds dropped by 3 basis points.
6 m ago
British statement: Large-scale and rapid entry of humanitarian aid must be allowed. Reiterating calls for an immediate ceasefire.
7 m ago
The Qingcheng Ultra-Intelligent "Red Hare" reasoning engine is compatible with the Zhifu's new flagship model GLM-4.5, with initial support for Huawei Ascend 910B.
8 m ago
Chilean Finance Minister: We hope that copper tariffs can be included in the US trade negotiation agenda starting on Monday. Chile will request that any copper tariffs imposed by the US be included in the scope of the comprehensive trade agreement.
See all latestmore
logo
Contact US
qr
+852 - 60190728
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.